JP Morgan Chase’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-34,869
| Closed | -$943K | – | 7772 |
|
|
2024
Q2 | $943K | Buy |
34,869
+599
| +2% | +$12.5K | ﹤0.01% | 4319 |
|
|
2024
Q1 | $628K | Sell |
34,270
-74,368
| -68% | -$1.18M | ﹤0.01% | 4646 |
|
|
2023
Q4 | $1.33M | Buy |
108,638
+38,234
| +54% | +$359K | ﹤0.01% | 4136 |
|
|
2023
Q3 | $1.06M | Sell |
70,404
-37,808
| -35% | -$787K | ﹤0.01% | 4028 |
|
|
2023
Q2 | $3.52M | Sell |
108,212
-97,248
| -47% | -$3.55M | ﹤0.01% | 3135 |
|
|
2023
Q1 | $8.04M | Buy |
205,460
+102,661
| +100% | +$5.02M | ﹤0.01% | 2470 |
|
|
2022
Q4 | $5.43M | Sell |
102,799
-12,300
| -11% | -$599K | ﹤0.01% | 2752 |
|
|
2022
Q3 | $5.18M | Sell |
115,099
-3,411
| -3% | -$147K | ﹤0.01% | 2712 |
|
|
2022
Q2 | $4.31M | Buy |
118,510
+48,951
| +70% | +$1.78M | ﹤0.01% | 2909 |
|
|
2022
Q1 | $2.87M | Sell |
69,559
-337
| -0.5% | -$11.9K | ﹤0.01% | 3473 |
|
|
2021
Q4 | $2.98M | Sell |
69,896
-11,958
| -15% | -$598K | ﹤0.01% | 3501 |
|
|
2021
Q3 | $4.5M | Sell |
81,854
-3,293
| -4% | -$172K | ﹤0.01% | 3123 |
|
|
2021
Q2 | $4.08M | Sell |
85,147
-12,842
| -13% | -$654K | ﹤0.01% | 3236 |
|
|
2021
Q1 | $4.96M | Buy |
97,989
+42,129
| +75% | +$2.34M | ﹤0.01% | 2979 |
|
|
2020
Q4 | $3.52M | Buy |
55,860
+44,919
| +411% | +$2.79M | ﹤0.01% | 3080 |
|
|
2020
Q3 | $746K | Sell |
10,941
-1,523
| -12% | -$83.1K | ﹤0.01% | 3793 |
|
|
2020
Q2 | $521K | Sell |
12,464
-14,411
| -54% | -$553K | ﹤0.01% | 3832 |
|
|
2020
Q1 | $847K | Buy |
26,875
+16,761
| +166% | +$671K | ﹤0.01% | 3504 |
|
|
2019
Q4 | $408K | Buy |
10,114
+3,879
| +62% | +$136K | ﹤0.01% | 4339 |
|
|
2019
Q3 | $203K | Buy |
6,235
+3,023
| +94% | +$120K | ﹤0.01% | 4624 |
|
|
2019
Q2 | $149K | Buy |
+3,212
| New | +$137K | ﹤0.01% | 4780 |
|
Other funds holding SILK
JP Morgan Chase's SILK Position: Q3 2024 in Review
JP Morgan Chase sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 34,869 shares — an estimated $943K sold.
JP Morgan Chase first reported a position in SILK in Q2 2019 and held it in 21 quarters. The position peaked at $8.04M in Q1 2023. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.
- JP Morgan Chase reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- JP Morgan Chase sold 34,869 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $943K.
- JP Morgan Chase first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 21 quarters.
- JP Morgan Chase's Silk Road Medical, Inc. Common Stock position peaked at $8.04M in Q1 2023.
- 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.
Based on JP Morgan Chase's 13F filing for Q3 2024, filed 8 Nov 2024.